nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SHBG—hindlimb—muscle cancer	0.0598	0.176	CbGeAlD
Mitotane—Gastrointestinal toxicity—Etoposide—muscle cancer	0.0392	0.0594	CcSEcCtD
Mitotane—Growth retardation—Dactinomycin—muscle cancer	0.0392	0.0593	CcSEcCtD
Mitotane—FDX1—renal system—muscle cancer	0.0354	0.104	CbGeAlD
Mitotane—FDX1—cardiac atrium—muscle cancer	0.0317	0.0935	CbGeAlD
Mitotane—FDX1—tendon—muscle cancer	0.0277	0.0815	CbGeAlD
Mitotane—FDX1—bone marrow—muscle cancer	0.0268	0.0789	CbGeAlD
Mitotane—FDX1—vagina—muscle cancer	0.0257	0.0756	CbGeAlD
Mitotane—FDX1—head—muscle cancer	0.0237	0.0698	CbGeAlD
Mitotane—Gastrointestinal toxicity—Methotrexate—muscle cancer	0.0235	0.0356	CcSEcCtD
Mitotane—FDX1—testis—muscle cancer	0.0229	0.0675	CbGeAlD
Mitotane—Gastrointestinal toxicity—Doxorubicin—muscle cancer	0.0203	0.0308	CcSEcCtD
Mitotane—Speech impairment NOS—Methotrexate—muscle cancer	0.0177	0.0267	CcSEcCtD
Mitotane—Cystitis haemorrhagic—Doxorubicin—muscle cancer	0.0166	0.0252	CcSEcCtD
Mitotane—SERPINA6—renal system—muscle cancer	0.0153	0.0451	CbGeAlD
Mitotane—Mucosal inflammation—Etoposide—muscle cancer	0.0116	0.0176	CcSEcCtD
Mitotane—SERPINA6—bone marrow—muscle cancer	0.0116	0.0341	CbGeAlD
Mitotane—Retinal disorder—Methotrexate—muscle cancer	0.0108	0.0163	CcSEcCtD
Mitotane—CYP11A1—head—muscle cancer	0.0108	0.0317	CbGeAlD
Mitotane—CYP11A1—testis—muscle cancer	0.0104	0.0307	CbGeAlD
Mitotane—Polyneuropathy—Doxorubicin—muscle cancer	0.0102	0.0155	CcSEcCtD
Mitotane—SERPINA6—head—muscle cancer	0.0102	0.0302	CbGeAlD
Mitotane—SHBG—bone marrow—muscle cancer	0.00975	0.0287	CbGeAlD
Mitotane—SHBG—vagina—muscle cancer	0.00934	0.0275	CbGeAlD
Mitotane—SHBG—testis—muscle cancer	0.00834	0.0246	CbGeAlD
Mitotane—Mucosal inflammation—Methotrexate—muscle cancer	0.00697	0.0105	CcSEcCtD
Mitotane—Lethargy—Dactinomycin—muscle cancer	0.00659	0.00997	CcSEcCtD
Mitotane—Mucosal inflammation—Doxorubicin—muscle cancer	0.00603	0.00913	CcSEcCtD
Mitotane—Encephalopathy—Methotrexate—muscle cancer	0.00601	0.00909	CcSEcCtD
Mitotane—Ataxia—Vincristine—muscle cancer	0.00542	0.00821	CcSEcCtD
Mitotane—Myasthenia—Doxorubicin—muscle cancer	0.00531	0.00804	CcSEcCtD
Mitotane—Neutropenia—Dactinomycin—muscle cancer	0.00522	0.0079	CcSEcCtD
Mitotane—Muscular weakness—Vincristine—muscle cancer	0.00509	0.0077	CcSEcCtD
Mitotane—Fungal infection—Methotrexate—muscle cancer	0.00499	0.00756	CcSEcCtD
Mitotane—Neutropenia—Vincristine—muscle cancer	0.00466	0.00706	CcSEcCtD
Mitotane—Dermatitis atopic—Doxorubicin—muscle cancer	0.00451	0.00683	CcSEcCtD
Mitotane—Speech disorder—Methotrexate—muscle cancer	0.00448	0.00679	CcSEcCtD
Mitotane—Albuminuria—Doxorubicin—muscle cancer	0.00447	0.00677	CcSEcCtD
Mitotane—Hepatitis—Dactinomycin—muscle cancer	0.00447	0.00676	CcSEcCtD
Mitotane—Proteinuria—Methotrexate—muscle cancer	0.00439	0.00664	CcSEcCtD
Mitotane—Protein urine present—Methotrexate—muscle cancer	0.00433	0.00655	CcSEcCtD
Mitotane—Fungal infection—Doxorubicin—muscle cancer	0.00432	0.00655	CcSEcCtD
Mitotane—Flushing—Dactinomycin—muscle cancer	0.00415	0.00628	CcSEcCtD
Mitotane—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00408	0.00617	CcSEcCtD
Mitotane—Dysarthria—Methotrexate—muscle cancer	0.00408	0.00617	CcSEcCtD
Mitotane—Liver injury—Doxorubicin—muscle cancer	0.00397	0.00601	CcSEcCtD
Mitotane—Urinary tract disorder—Vincristine—muscle cancer	0.00394	0.00597	CcSEcCtD
Mitotane—Connective tissue disorder—Vincristine—muscle cancer	0.00392	0.00594	CcSEcCtD
Mitotane—Urethral disorder—Vincristine—muscle cancer	0.00391	0.00592	CcSEcCtD
Mitotane—Neutropenia—Etoposide—muscle cancer	0.00378	0.00572	CcSEcCtD
Mitotane—Angiopathy—Vincristine—muscle cancer	0.00362	0.00548	CcSEcCtD
Mitotane—Infestation NOS—Etoposide—muscle cancer	0.0036	0.00545	CcSEcCtD
Mitotane—Infestation—Etoposide—muscle cancer	0.0036	0.00545	CcSEcCtD
Mitotane—Anaemia—Dactinomycin—muscle cancer	0.00359	0.00544	CcSEcCtD
Mitotane—Dyskinesia—Doxorubicin—muscle cancer	0.00355	0.00538	CcSEcCtD
Mitotane—Dysarthria—Doxorubicin—muscle cancer	0.00353	0.00534	CcSEcCtD
Mitotane—Mental disorder—Vincristine—muscle cancer	0.0035	0.00529	CcSEcCtD
Mitotane—Neoplasm—Methotrexate—muscle cancer	0.00349	0.00528	CcSEcCtD
Mitotane—Gynaecomastia—Methotrexate—muscle cancer	0.00345	0.00522	CcSEcCtD
Mitotane—Hepatobiliary disease—Etoposide—muscle cancer	0.00341	0.00516	CcSEcCtD
Mitotane—Hepatocellular injury—Doxorubicin—muscle cancer	0.00334	0.00505	CcSEcCtD
Mitotane—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00324	0.00491	CcSEcCtD
Mitotane—Anaemia—Vincristine—muscle cancer	0.00321	0.00486	CcSEcCtD
Mitotane—Urinary tract disorder—Etoposide—muscle cancer	0.00319	0.00483	CcSEcCtD
Mitotane—Urethral disorder—Etoposide—muscle cancer	0.00317	0.0048	CcSEcCtD
Mitotane—Infection—Dactinomycin—muscle cancer	0.00315	0.00477	CcSEcCtD
Mitotane—Vertigo—Vincristine—muscle cancer	0.00312	0.00473	CcSEcCtD
Mitotane—Thrombocytopenia—Dactinomycin—muscle cancer	0.00311	0.0047	CcSEcCtD
Mitotane—Anorexia—Dactinomycin—muscle cancer	0.00303	0.00458	CcSEcCtD
Mitotane—Eye disorder—Etoposide—muscle cancer	0.00302	0.00457	CcSEcCtD
Mitotane—Neoplasm—Doxorubicin—muscle cancer	0.00302	0.00457	CcSEcCtD
Mitotane—Flushing—Etoposide—muscle cancer	0.003	0.00454	CcSEcCtD
Mitotane—Hypertension—Vincristine—muscle cancer	0.003	0.00454	CcSEcCtD
Mitotane—Angiopathy—Etoposide—muscle cancer	0.00293	0.00444	CcSEcCtD
Mitotane—Mental disability—Doxorubicin—muscle cancer	0.0029	0.00439	CcSEcCtD
Mitotane—Lethargy—Methotrexate—muscle cancer	0.00286	0.00432	CcSEcCtD
Mitotane—Infection—Vincristine—muscle cancer	0.00282	0.00426	CcSEcCtD
Mitotane—Osteoarthritis—Methotrexate—muscle cancer	0.0028	0.00424	CcSEcCtD
Mitotane—Nervous system disorder—Vincristine—muscle cancer	0.00278	0.00421	CcSEcCtD
Mitotane—Thrombocytopenia—Vincristine—muscle cancer	0.00278	0.0042	CcSEcCtD
Mitotane—Decreased appetite—Dactinomycin—muscle cancer	0.00276	0.00418	CcSEcCtD
Mitotane—Dysgeusia—Etoposide—muscle cancer	0.00276	0.00417	CcSEcCtD
Mitotane—Pain—Dactinomycin—muscle cancer	0.00271	0.00411	CcSEcCtD
Mitotane—Anorexia—Vincristine—muscle cancer	0.0027	0.00409	CcSEcCtD
Mitotane—Irritability—Methotrexate—muscle cancer	0.00267	0.00404	CcSEcCtD
Mitotane—Hypotension—Vincristine—muscle cancer	0.00265	0.00401	CcSEcCtD
Mitotane—Ataxia—Methotrexate—muscle cancer	0.00263	0.00398	CcSEcCtD
Mitotane—Feeling abnormal—Dactinomycin—muscle cancer	0.00262	0.00396	CcSEcCtD
Mitotane—Anaemia—Etoposide—muscle cancer	0.0026	0.00394	CcSEcCtD
Mitotane—Paraesthesia—Vincristine—muscle cancer	0.00255	0.00385	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—muscle cancer	0.00253	0.00383	CcSEcCtD
Mitotane—Vertigo—Etoposide—muscle cancer	0.00253	0.00383	CcSEcCtD
Mitotane—Body temperature increased—Dactinomycin—muscle cancer	0.00251	0.0038	CcSEcCtD
Mitotane—Lethargy—Doxorubicin—muscle cancer	0.00247	0.00374	CcSEcCtD
Mitotane—Decreased appetite—Vincristine—muscle cancer	0.00246	0.00373	CcSEcCtD
Mitotane—Gastrointestinal disorder—Vincristine—muscle cancer	0.00245	0.00371	CcSEcCtD
Mitotane—Hypertension—Etoposide—muscle cancer	0.00243	0.00368	CcSEcCtD
Mitotane—Pain—Vincristine—muscle cancer	0.00242	0.00367	CcSEcCtD
Mitotane—Diplopia—Doxorubicin—muscle cancer	0.00242	0.00367	CcSEcCtD
Mitotane—Osteoarthritis—Doxorubicin—muscle cancer	0.00242	0.00367	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00238	0.0036	CcSEcCtD
Mitotane—Hypersensitivity—Dactinomycin—muscle cancer	0.00234	0.00354	CcSEcCtD
Mitotane—Confusional state—Etoposide—muscle cancer	0.00232	0.00351	CcSEcCtD
Mitotane—Infection—Etoposide—muscle cancer	0.00228	0.00345	CcSEcCtD
Mitotane—Ataxia—Doxorubicin—muscle cancer	0.00228	0.00345	CcSEcCtD
Mitotane—Asthenia—Dactinomycin—muscle cancer	0.00228	0.00345	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—muscle cancer	0.00226	0.00342	CcSEcCtD
Mitotane—Thrombocytopenia—Etoposide—muscle cancer	0.00225	0.0034	CcSEcCtD
Mitotane—Body temperature increased—Vincristine—muscle cancer	0.00224	0.00339	CcSEcCtD
Mitotane—Skin disorder—Etoposide—muscle cancer	0.00223	0.00338	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00221	0.00335	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—muscle cancer	0.00219	0.00332	CcSEcCtD
Mitotane—Anorexia—Etoposide—muscle cancer	0.00219	0.00331	CcSEcCtD
Mitotane—Diarrhoea—Dactinomycin—muscle cancer	0.00217	0.00329	CcSEcCtD
Mitotane—Infestation—Methotrexate—muscle cancer	0.00216	0.00327	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—muscle cancer	0.00216	0.00327	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—muscle cancer	0.00216	0.00327	CcSEcCtD
Mitotane—Hypotension—Etoposide—muscle cancer	0.00215	0.00325	CcSEcCtD
Mitotane—Muscular weakness—Doxorubicin—muscle cancer	0.00214	0.00324	CcSEcCtD
Mitotane—Hypersensitivity—Vincristine—muscle cancer	0.00209	0.00316	CcSEcCtD
Mitotane—Paraesthesia—Etoposide—muscle cancer	0.00206	0.00312	CcSEcCtD
Mitotane—Haematuria—Methotrexate—muscle cancer	0.00206	0.00311	CcSEcCtD
Mitotane—Somnolence—Etoposide—muscle cancer	0.00204	0.00309	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—muscle cancer	0.00204	0.00309	CcSEcCtD
Mitotane—Asthenia—Vincristine—muscle cancer	0.00203	0.00308	CcSEcCtD
Mitotane—Vomiting—Dactinomycin—muscle cancer	0.00202	0.00305	CcSEcCtD
Mitotane—Rash—Dactinomycin—muscle cancer	0.002	0.00303	CcSEcCtD
Mitotane—Decreased appetite—Etoposide—muscle cancer	0.002	0.00302	CcSEcCtD
Mitotane—Gastrointestinal disorder—Etoposide—muscle cancer	0.00198	0.003	CcSEcCtD
Mitotane—Pain—Etoposide—muscle cancer	0.00196	0.00297	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—muscle cancer	0.00196	0.00297	CcSEcCtD
Mitotane—Diarrhoea—Vincristine—muscle cancer	0.00194	0.00294	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—muscle cancer	0.00194	0.00293	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—muscle cancer	0.00191	0.00289	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—muscle cancer	0.0019	0.00287	CcSEcCtD
Mitotane—Feeling abnormal—Etoposide—muscle cancer	0.00189	0.00287	CcSEcCtD
Mitotane—Nausea—Dactinomycin—muscle cancer	0.00189	0.00285	CcSEcCtD
Mitotane—Dizziness—Vincristine—muscle cancer	0.00188	0.00284	CcSEcCtD
Mitotane—Infestation—Doxorubicin—muscle cancer	0.00187	0.00283	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—muscle cancer	0.00187	0.00283	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—muscle cancer	0.00187	0.00283	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—muscle cancer	0.00187	0.00283	CcSEcCtD
Mitotane—Body temperature increased—Etoposide—muscle cancer	0.00182	0.00275	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—muscle cancer	0.00181	0.00274	CcSEcCtD
Mitotane—Vomiting—Vincristine—muscle cancer	0.0018	0.00273	CcSEcCtD
Mitotane—Rash—Vincristine—muscle cancer	0.00179	0.00271	CcSEcCtD
Mitotane—Dermatitis—Vincristine—muscle cancer	0.00179	0.0027	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—muscle cancer	0.00178	0.0027	CcSEcCtD
Mitotane—Headache—Vincristine—muscle cancer	0.00178	0.00269	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00177	0.00267	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—muscle cancer	0.00176	0.00266	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—muscle cancer	0.0017	0.00257	CcSEcCtD
Mitotane—Hypersensitivity—Etoposide—muscle cancer	0.00169	0.00256	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—muscle cancer	0.00169	0.00255	CcSEcCtD
Mitotane—Nausea—Vincristine—muscle cancer	0.00168	0.00255	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—muscle cancer	0.00168	0.00254	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—muscle cancer	0.00166	0.00251	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—muscle cancer	0.00165	0.0025	CcSEcCtD
Mitotane—Asthenia—Etoposide—muscle cancer	0.00165	0.00249	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—muscle cancer	0.00165	0.00249	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—muscle cancer	0.00164	0.00249	CcSEcCtD
Mitotane—Visual impairment—Doxorubicin—muscle cancer	0.00162	0.00245	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—muscle cancer	0.00159	0.0024	CcSEcCtD
Mitotane—Diarrhoea—Etoposide—muscle cancer	0.00157	0.00238	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—muscle cancer	0.00157	0.00237	CcSEcCtD
Mitotane—Anaemia—Methotrexate—muscle cancer	0.00156	0.00236	CcSEcCtD
Mitotane—Flushing—Doxorubicin—muscle cancer	0.00156	0.00236	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—muscle cancer	0.00152	0.0023	CcSEcCtD
Mitotane—Dizziness—Etoposide—muscle cancer	0.00152	0.0023	CcSEcCtD
Mitotane—Vertigo—Methotrexate—muscle cancer	0.00151	0.00229	CcSEcCtD
Mitotane—Mental disorder—Doxorubicin—muscle cancer	0.00147	0.00222	CcSEcCtD
Mitotane—Vomiting—Etoposide—muscle cancer	0.00146	0.00221	CcSEcCtD
Mitotane—Malnutrition—Doxorubicin—muscle cancer	0.00146	0.00221	CcSEcCtD
Mitotane—Rash—Etoposide—muscle cancer	0.00145	0.00219	CcSEcCtD
Mitotane—Dermatitis—Etoposide—muscle cancer	0.00145	0.00219	CcSEcCtD
Mitotane—Headache—Etoposide—muscle cancer	0.00144	0.00218	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—muscle cancer	0.00143	0.00216	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00143	0.00216	CcSEcCtD
Mitotane—Confusional state—Methotrexate—muscle cancer	0.00139	0.0021	CcSEcCtD
Mitotane—Vision blurred—Doxorubicin—muscle cancer	0.00138	0.00208	CcSEcCtD
Mitotane—Infection—Methotrexate—muscle cancer	0.00137	0.00207	CcSEcCtD
Mitotane—Nausea—Etoposide—muscle cancer	0.00136	0.00207	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—muscle cancer	0.00135	0.00204	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—muscle cancer	0.00135	0.00204	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—muscle cancer	0.00135	0.00204	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—muscle cancer	0.00134	0.00202	CcSEcCtD
Mitotane—Vertigo—Doxorubicin—muscle cancer	0.00131	0.00199	CcSEcCtD
Mitotane—Anorexia—Methotrexate—muscle cancer	0.00131	0.00199	CcSEcCtD
Mitotane—Hypotension—Methotrexate—muscle cancer	0.00129	0.00195	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—muscle cancer	0.00126	0.00191	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—muscle cancer	0.00124	0.00187	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00123	0.00187	CcSEcCtD
Mitotane—Somnolence—Methotrexate—muscle cancer	0.00122	0.00185	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—muscle cancer	0.00121	0.00183	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—muscle cancer	0.0012	0.00182	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—muscle cancer	0.0012	0.00181	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00119	0.0018	CcSEcCtD
Mitotane—Infection—Doxorubicin—muscle cancer	0.00118	0.00179	CcSEcCtD
Mitotane—Pain—Methotrexate—muscle cancer	0.00118	0.00178	CcSEcCtD
Mitotane—Shock—Doxorubicin—muscle cancer	0.00117	0.00177	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—muscle cancer	0.00117	0.00177	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—muscle cancer	0.00117	0.00177	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—muscle cancer	0.00116	0.00175	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—muscle cancer	0.00114	0.00172	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—muscle cancer	0.00113	0.00172	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—muscle cancer	0.00111	0.00169	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—muscle cancer	0.00109	0.00165	CcSEcCtD
Mitotane—Paraesthesia—Doxorubicin—muscle cancer	0.00107	0.00162	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—muscle cancer	0.00106	0.0016	CcSEcCtD
Mitotane—Dyspepsia—Doxorubicin—muscle cancer	0.00105	0.00159	CcSEcCtD
Mitotane—Decreased appetite—Doxorubicin—muscle cancer	0.00104	0.00157	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00103	0.00156	CcSEcCtD
Mitotane—Pain—Doxorubicin—muscle cancer	0.00102	0.00154	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—muscle cancer	0.00101	0.00153	CcSEcCtD
Mitotane—Asthenia—Methotrexate—muscle cancer	0.000987	0.00149	CcSEcCtD
Mitotane—Feeling abnormal—Doxorubicin—muscle cancer	0.000982	0.00149	CcSEcCtD
Mitotane—Body temperature increased—Doxorubicin—muscle cancer	0.000942	0.00143	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—muscle cancer	0.000941	0.00142	CcSEcCtD
Mitotane—Dizziness—Methotrexate—muscle cancer	0.00091	0.00138	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—muscle cancer	0.000878	0.00133	CcSEcCtD
Mitotane—Vomiting—Methotrexate—muscle cancer	0.000875	0.00132	CcSEcCtD
Mitotane—Rash—Methotrexate—muscle cancer	0.000868	0.00131	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—muscle cancer	0.000867	0.00131	CcSEcCtD
Mitotane—Headache—Methotrexate—muscle cancer	0.000862	0.0013	CcSEcCtD
Mitotane—Asthenia—Doxorubicin—muscle cancer	0.000855	0.00129	CcSEcCtD
Mitotane—Nausea—Methotrexate—muscle cancer	0.000817	0.00124	CcSEcCtD
Mitotane—Diarrhoea—Doxorubicin—muscle cancer	0.000815	0.00123	CcSEcCtD
Mitotane—Dizziness—Doxorubicin—muscle cancer	0.000788	0.00119	CcSEcCtD
Mitotane—Vomiting—Doxorubicin—muscle cancer	0.000758	0.00115	CcSEcCtD
Mitotane—Rash—Doxorubicin—muscle cancer	0.000751	0.00114	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—muscle cancer	0.00075	0.00114	CcSEcCtD
Mitotane—Headache—Doxorubicin—muscle cancer	0.000746	0.00113	CcSEcCtD
Mitotane—Nausea—Doxorubicin—muscle cancer	0.000708	0.00107	CcSEcCtD
